Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma
Efficacy of RNFL / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma
1 other identifier
observational
400
1 country
1
Brief Summary
Glaucoma is presumed to be an axonal disease which starts at the lamina cribrosa. This assumption has led to the monitoring of the retinal nerve fiber layer thickness for the diagnosis and monitoring of progression of glaucoma. However, varying disc size, myopia and tilted discs affect the thickness of the retinal nerve fiber layer. This study aims to ascertain the ration of the retinal nerve fiber layer against full retina as a predictor of glaucoma diagnosis and progression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 15, 2008
CompletedFirst Posted
Study publicly available on registry
October 16, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedOctober 16, 2008
October 1, 2008
2 months
October 15, 2008
October 15, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ratio of RNFL / Full thickness retina
2 months
Study Arms (4)
1
Primary open angle glaucoma
2
Normal Control
3
Myopia with no evidence of glaucoma
4
Myopia with evidence og glaucoma
Eligibility Criteria
prospective consecutive recruitment from a tertialry glaucoma subspecialty practise
You may qualify if:
- Primary open angle glaucoma
- Myopia
- Myopia with evidence of glaucoma
- Normal controls
You may not qualify if:
- Evidence of retinal disease
- BCVA \< 0.4
- Secondary glaucoma due to intraocular inflammation
- Lens induced glaucoma
- Tumor induced glaucoma
- Neovascular glaucoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University School of Medicine
Seoul, 120-752, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 15, 2008
First Posted
October 16, 2008
Study Start
October 1, 2008
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
October 16, 2008
Record last verified: 2008-10